379 related articles for article (PubMed ID: 15368281)
1. Self-peptides that bind with low affinity to the diabetes-associated I-A(g7) molecule readily induce T cell tolerance in non-obese diabetic mice.
Ferlin WG; Mougneau E; Hugues S; Appel H; Jang MH; Cazareth J; Beaudoin L; Schricke C; Lehuen A; Wucherpfennig KW; Glaichenhaus N
Eur J Immunol; 2004 Oct; 34(10):2656-63. PubMed ID: 15368281
[TBL] [Abstract][Full Text] [Related]
2. Regulation of type 1 diabetes by a self-MHC class II peptide: role of transforming growth factor beta (TGF-beta).
Mukherjee R; Chaturvedi P; Agrawal B; Singh B
Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):159-69. PubMed ID: 12887099
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactive mycobacterial and self hsp60 epitope recognition in I-A(g7) expressing NOD, NOD-asp and Biozzi AB/H mice.
van Halteren AG; Roep BO; Gregori S; Cooke A; van Eden W; Kraal G; Wauben MH
J Autoimmun; 2002 Mar; 18(2):139-47. PubMed ID: 11908946
[TBL] [Abstract][Full Text] [Related]
4. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection.
Hanson MS; Cetkovic-Cvrlje M; Ramiya VK; Atkinson MA; Maclaren NK; Singh B; Elliott JF; Serreze DV; Leiter EH
J Immunol; 1996 Aug; 157(3):1279-87. PubMed ID: 8757636
[TBL] [Abstract][Full Text] [Related]
5. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
[TBL] [Abstract][Full Text] [Related]
6. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice.
Reich EP; von Grafenstein H; Barlow A; Swenson KE; Williams K; Janeway CA
J Immunol; 1994 Mar; 152(5):2279-88. PubMed ID: 8133041
[TBL] [Abstract][Full Text] [Related]
7. Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.
Ranheim EA; Tarbell KV; Krogsgaard M; Mallet-Designe V; Teyton L; McDevitt HO; Weissman IL
Autoimmunity; 2004 Dec; 37(8):555-67. PubMed ID: 15763918
[TBL] [Abstract][Full Text] [Related]
8. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
Agrawal B; Manickasundari M; Fraga E; Singh B
J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
[TBL] [Abstract][Full Text] [Related]
9. Peptide analysis, stability studies, and structural modeling explain contradictory peptide motifs and unique properties of the NOD mouse MHC class II molecule H2-A(g7).
Münz C; Hofmann M; Yoshida K; Moustakas AK; Kikutani H; Stevanoviç S; Papadopoulos GK; Rammensee HG
Eur J Immunol; 2002 Aug; 32(8):2105-16. PubMed ID: 12209622
[TBL] [Abstract][Full Text] [Related]
10. Peripheral T cell clones from NOD mice specific for GAD65 peptides: lack of islet responsiveness or diabetogenicity.
Schloot NC; Daniel D; Norbury-Glaser M; Wegmann DR
J Autoimmun; 1996 Jun; 9(3):357-63. PubMed ID: 8816971
[TBL] [Abstract][Full Text] [Related]
11. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
12. Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.
Nabavieh A; Chou H; Volokhov I; Lee JE; Purdy LE; Elliott JF; Singh B; Madrenas J
J Autoimmun; 1998 Feb; 11(1):63-71. PubMed ID: 9480724
[TBL] [Abstract][Full Text] [Related]
13. T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD(524-543).
Quinn A; Sercarz EE
J Autoimmun; 1996 Jun; 9(3):365-70. PubMed ID: 8816972
[TBL] [Abstract][Full Text] [Related]
14. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
[TBL] [Abstract][Full Text] [Related]
15. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
[TBL] [Abstract][Full Text] [Related]
16. Suppression of type 1 diabetes in NOD mice by bifunctional peptide inhibitor: modulation of the immunological synapse formation.
Murray JS; Oney S; Page JE; Kratochvil-Stava A; Hu Y; Makagiansar IT; Brown JC; Kobayashi N; Siahaan TJ
Chem Biol Drug Des; 2007 Sep; 70(3):227-36. PubMed ID: 17718717
[TBL] [Abstract][Full Text] [Related]
17. Absence of T cell tolerance to pancreatic islet cells.
Burtles SS; Trembleau S; Drexler K; Hurtenbach U
J Immunol; 1992 Sep; 149(6):2185-93. PubMed ID: 1355504
[TBL] [Abstract][Full Text] [Related]
18. Both central and peripheral tolerance mechanisms play roles in diabetes prevention in NOD-E transgenic mice.
Mellanby RJ; Phillips JM; Parish NM; Cooke A
Autoimmunity; 2008 Aug; 41(5):383-94. PubMed ID: 18568644
[TBL] [Abstract][Full Text] [Related]
19. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.
Carrasco-Marin E; Shimizu J; Kanagawa O; Unanue ER
J Immunol; 1996 Jan; 156(2):450-8. PubMed ID: 8543793
[TBL] [Abstract][Full Text] [Related]
20. T cell tolerance is influenced by concomitant T cell recognition of cross-reactive self-peptides.
Tam RC; Fedoseyeva EV; Moskalenko M; Garovoy MR; Benichou G
J Immunol; 1996 May; 156(10):3765-71. PubMed ID: 8621912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
